HOME › DRUGS › CANDESARTAN CILEXETIL
ACTIVE SUBSTANCE / INN

CANDESARTAN CILEXETIL

Brand name(s): CANDESARTAN CILEXETIL, ATACAND, CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, ATACAND HCT
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA021093
ANDA207455
ACTIVE SUBSTANCE
Candesartan Cilexetil
REGULATORS
FDA
SPONSORS / MAH
APOTEX, TEVA PHARMS USA, PRINSTON INC
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ATACANDNDA020838ANI PHARMSPrescription
CANDESARTAN CILEXETILANDA206233PRINSTON INCPrescription
ATACAND HCTNDA021093ANI PHARMSPrescription
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEANDA207455PRINSTON INCPrescription
CANDESARTAN CILEXETILANDA202079APOTEXDiscontinued
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEANDA200887TEVA PHARMS USANone (Tentative Approval)
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEANDA202884APOTEX INCDiscontinued

FULL INTELLIGENCE ON CANDESARTAN CILEXETIL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →